1 / 25

GENERAL INFORMATION ABOUT AKVION COMPANY

GENERAL INFORMATION ABOUT AKVION COMPANY. 2. THE MISSION OF THE COMPANY. We make products that improve quality of life. AKVION company’s products : Are based on unique ideas. Have no analogues. Produced by proprietary technologies. 3.

tirzah
Download Presentation

GENERAL INFORMATION ABOUT AKVION COMPANY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GENERAL INFORMATIONABOUT AKVION COMPANY 2

  2. THE MISSION OF THE COMPANY We make products that improve quality of life • AKVION company’s products: • Are based on unique ideas. • Have no analogues. • Produced by proprietary technologies. 3

  3. DYNAMICS OF ANNUAL TURNOVER GROWTH OF THE AKVION COMPANY Manufacturers of multivitamin supplements in the 1-st half of 2011 * Manufacturers of FS in the 1-st half of 2011 * ______________________ * Data of Central Medical Institution «Pharmexpert» 4

  4. ALFAVIT series of vitamin and mineral complexes • Includes all vitamins and minerals necessary for children older than 14 years and adults. • Unlike other systems takes into account scientific recommendations on separate and combined reception of nutrients. As a result: • vitamin prophylaxis is more effective on the average for 30-50 %; • minimizes probability of allergic reactions. 5

  5. POPULARITY OF ALFAVIT ______________________ * Own data of shipments. ** According to the results of R-TGI studies conducted by COMCON-Pharma. 6

  6. QUDESAN formulation for CVS integrated support • Is a source of coenzyme Q10, which: • is recommended for prophylaxis and complex therapy of CVS diseases; • is used in treatment of chronic fatigue syndrome. • fights with age-related alterations. • Efficiency and safety are proved by many years of usage. • Optimalforabsorption formofcoenzyme Q10. Available in various forms (chewable tablets for children 3 years old, solution and tablets for adults). In 2010 Qudesan (solution) is registered as a drug. ______________________ * Own data of shipments. 7

  7. VETORON for children and VETORON-E preparations for enhancement of the immune system • Is a source of beta-carotene, which: • fortifies the immune system of the children and adults; • reduces the risk of respiratory diseases; • reduces the likelihood of complications from respiratory diseases, accelerates the healing process. • Safe: there is minimal possibility of overdose and side effects. Available in various forms (solution and chewable tablets for children 3 years old, and solution for adults). In 2010 Vetoron for Kids (solution) is registered as a drug. ______________________ * Own data of shipments. 8

  8. FOCUS vitamin-mineral complexes for eyes • Contain a balanced amount of anthocyanins, carotenoids and other essential micronutrients eyes. • Modern and high quality products, superior competitors in the amount of characteristics. Easy to use: take 1 capsule or 1 tablet per day. ______________________ * Own data of shipments. 9

  9. DYSHI OIL a composition of natural essential oils Recommendedforthepreventionofcolds • The composition includes 6 essential oils. • Is efficient at the initial stages of common cold, prevents the development of cold-related diseases. • Disinfects the air and reduces the risk for people that are near the sick person. • Is safe in use: does not dry the nasal mucosa and is nonaddictive. Since the autumn of 2011 Olbas oil was changed on Dyshi oil in the range of AKVION. 10

  10. CARNITON the source of L-carnitine • It is the source of L-carnitine, which: • increases the working capacity and reduces fatigability. • is required in case of increased physical, mental and emotional stresses. • helps to regain strength after illnesses. Available in various forms (solution and tablets). ______________________ * Own data of shipments. 11

  11. QUTEN nutricosmetic coenzyme Q10-based formulation for the fight against aging skin • One capsule of Quten contains 100% of Q10 daily value, which: • slowstheagingprocess: • improvesskinelasticity, • reducesthenumberanddepthofwrinkles; • stimulates the regeneration and restoration of the skin; • increasestheeffectivenessofexternalcosmetics; • protectsagainstunwanted UV radiation. ______________________ * Own data of shipments. 12

  12. SPEMATON AND PREGNOTON the complex of preparations for birth planning In pharmacies – from April 2012 • Spematon enhances male fertility. • Pregnoton prepares the female body for pregnancy. • Easy to use: receiving a once a day. 13

  13. PROMOTION CHANNELS 14

  14. PRODUCTION manufacturing base – Vneshtorg Pharma Ltd. • VneshtorgPharma is licensed for production of medications and performs a full cycle of manufacturing operations: from production of premixes to packing of the final product. • License № 99-04-000875, issued on July 29, 2010. • For our products we use the raw materials from recognized suppliers in Russia and foreign countries, including Switzerland, Japan, France and Germany. • Analytical laboratory of the institution is accredited by the Russian Ministry of Health. • In 2009 after successful completion of repair works, the plant started production of sterile liquid dosage forms. 15

  15. INTERNATIONAL PARTNERS 16

  16. DISTRIBUTION 17

  17. COOPERATION WITH PHARMACY CHAINS The AKVION’s products are submitted in more than 95% of the pharmacies*. We cooperate with major pharmacy chains. ___________________ * According to own company’s data. 19

  18. PLANS OF PRODUCT PORTFOLIO DEVELOPMENT. CRITERIA OF DEVELOPMENT 18

  19. STAGES OF THE NEW PRODUCTS DEVELOPMENT 19

  20. EXPANSION OF PRODUCT PORTFOLIO: CURRENT SITUATION 20

  21. AWARDS AND ACHIEVEMENTS 21

  22. FOREIGN MARKETS In 2010 total sales of AKVION products in foreign markets amounted to € 2,6, accounting for 9,4% of total sales. _____________________ * Countries wherethe delivery of productshas recently so there is no data about sales. 22

  23. COOPERATION • AKVION company is interested in building partnerships through: • In-licensing in Russia and CIS countries (Kazakhstan, Belarus, Ukraine). • Exclusive distribution in Russia and CIS. • Cooperation with foreign R&D-technology companies and laboratories. • Cooperation with foreign companies in countries where there is no representative of the company AKVION. 23

  24. CONCLUSION Thank you for your cooperation.Hope for its successful continuation. Data sources • Marketing research of medicines and bioactive additives «Komkon-Pharma» R-TGI. • Retail sales monitoring Central Medical Institution «Pharmexpert». • Internal AKVION data. • Retail sales monitoring «DSM Group». 24

More Related